Briar Capital
  • ABOUT US
  • INVESTMENT STRATEGY
  • NEWS
  • CONTACT US
  • 中文 (中国)
Select Page

Chongqing Precision Biotech initiates phase II clinical trial for children B-ALL

by admin | Jan 28, 2022 | news

“Tofu” cream. “Protein” lotion. “Ice white” facial masks. These are the nicknames that loyal Chinese fans of the skincare company Erno Laszlo have made up for the brand’s products. And when consumers get creative with pet-names for brands and products in China,...

Recent Posts

  • International Team Led by BGI Completes First Whole-Body Cell Atlas of a Non-Human Primate
  • Chongqing Precision Biotech initiates phase II clinical trial for children B-ALL
  • Innoforce Completes Second Tranche of Series A Financing
  • Hubei Angel-Synceres Biotechnology: towards building a 100 billion worth industrialization platform for synthetic biology
  • Jazz Pharmaceuticals Completes Acquisition of GW

Recent Comments

    Archives

    • May 2022
    • January 2022
    • December 2021
    • July 2021
    • May 2021
    • August 2019

    Categories

    • news

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Copyright © Briar Capital